Last reviewed · How we verify

NCT05891041

New Method for the Collection of the Output From the Ileostoma Using a Intestinal Tampon

Completed Last updated 29 December 2023
What this trial tests

trial in Ileostomy - Stoma in 24 participants. Completed in 1 October 2023.

Timeline
26 April 2023
Primary endpoint
25 September 2023
1 October 2023

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date26 April 2023
Primary completion25 September 2023
Estimated completion1 October 2023
Sites1 location across Denmark

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Ileostomy - Stoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1 study: A pilot study of 8 adults with ileostomy was included in this trial of "first in human" with InterPoc™, an absorbent intestinal tampon safety and feasibility in humans with ileostomies. Study 2: A study in total with 24 participants, evaluating both the safety but also the functionality of InterPoc in humans with ileostomies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ileostomy - Stoma

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05891041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing